CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil
Summary
GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil,. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Brazil. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Brazil. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the Brazil, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Sanofi, GSK, Pfizer, Novartis and Hypera) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, GE Healthcare, Roche, B Braun and Hologic)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Brazil
- Porter’s five forces analysis for pharmaceutical and medical devices market of Brazil
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Brazilian healthcare market.
Reasons to buyThis report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Italian healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Brazilian healthcare market.
- Executive Summary
- Overview of Pharmaceutical Market
- Overview of Medical Device Market
- Deals Analysis
- Porter’s Five Forces Model
- Market Access
- Country Healthcare Landscape
- Opportunities and Challenges
- Appendix
- List of Tables
- Table 1: Top Five Therapeutic Areas based on Mortality by Major Disease Areas (thousand), Brazil, 2016
- Table 2: Medical Device Market, Brazil, Revenue by Segment ($B), 2018
- Table 3: General Surgery Devices Market, Brazil, Revenue ($M) and Market Share (%) of Major Companies, 2018
- Table 4: Diagnostic Imaging Market, Brazil, Revenue ($B) and Market Share (%) of Major Companies, 2015
- Table 5: IVD Market, Brazil, Revenue ($B) and Market Share (%) of Major Companies, 2017
- Table 6:Ophthalmic Market, Brazil, Revenue ($B) and Market Share (%) of Major Companies, 2015
- Table 7: Orthopedic Devices Market, Brazil, Revenue ($M) and Market Share (%) of Major Companies, 2018
- Table 8: Patent Fees, Brazil, 2017
- Table 9: Trademarks Fees ($), Brazil, 2014
- List of Figures
- Figure 1: Pharmaceutical Market, Brazil, Revenue ($B), 2015-2020
- Figure 2: Medical Device Market, Brazil, Revenue ($B), 2015-2020
- Figure 3: Number of Deals (2018-2019)
- Figure 4: 2018-19 Deal Overview By Region
- Figure 5: Country Profile, Brazil, 2018
- Figure 6: Pharmaceutical Market, Brazil, Revenue ($B), 2010-2018
- Figure 7: Pharmaceutical Market, Brazil, Revenue Forecast ($B), 2019-2022
- Figure 8: Pharmaceutical Market, Brazil, Pharmaceutical Exports
- Figure 9: Pharmaceutical Market, Brazil, Top Export Partners
- Figure 10: Pharmaceutical Market, Brazil, Pharmaceutical Imports
- Figure 11: Pharmaceutical Market, Brazil, Top Import Partners
- Figure 12: Pharmaceutical Supply Channels, Brazil
- Figure 13: Generic Drugs Market, Brazil($B), 2010-2018
- Figure 14: OTC Product Group Sales ($M), Brazil, 2013-2016
- Figure 15: Top Five Therapeutic Areas based on Mortality by Major Disease Areas (thousand), Brazil, 2016
- Figure 16: Pharmaceutical Market, Major Players, Brazil
- Figure 17: Medical Device Market, Brazil, Revenue Forecast ($B), 2021-2025
- Figure 18: Medical Device Market, Brazil, Revenue by Segment ($B), 2018
- Figure 19: General Surgery Devices Market, Brazil, Revenue ($B), 2015-2022
- Figure 20: General Surgery Devices Market, Brazil, Market Share of Major Players (%), 2018
- Figure 21:Diagnostic Imaging Market, Brazil, Revenue ($B), 2015-2022
- Figure 22:Diagnostic Imaging Market, Brazil, Market Share of Major Players (%), 2015
- Figure 23:IVD Market, Brazil, Revenue ($B), 2015-2022
- Figure 24:IVD Market, Brazil, Market Share of Major Players (%), 2017
- Figure 25: Ophthalmic Devices Market, Brazil, Revenue ($B), 2015-2022
- Figure 26: Ophthalmic Market, Brazil, Revenue ($B) and Market Share (%) of Major Companies, 2015
- Figure 27: Orthopedic Devices Market, Brazil, Revenue ($M), 2015-2022
- Figure 28: Orthopedic Devices Market, Brazil, Revenue ($M) and Market Share (%) of Major Companies, 2018
- Figure 29: Diagnostic Market, Brazil, Revenue ($B), 2015-2018
- Figure 30: Diagnostic Market, Brazil, Revenue Forecast ($B), 2019-2022
- Figure 31: Medical Device Market - Major Players
- Figure 32: Deal Value and Deal Count, Pharmaceutical Market, Brazil, 2018-2019
- Figure 33: Deal Value and Deal Count, by Quarter, Pharmaceutical Market, Brazil, 2018-2019
- Figure 34: Deal Value and Deal Count, by Subtype, Pharmaceutical Market, Brazil, 2018-2019
- Figure 35: Top Three Therapy Areas by Deal Value, Pharmaceutical Market, Brazil, 2018-2019
- Figure 36:Top Five Therapy Areas by Deal Number, Pharmaceutical Market, Brazil, 2018-2019
- Figure 37: M&A Deals by Therapy Area by Value and Number, Pharmaceutical Market, Brazil, 2018-2019
- Figure 38: Medical Device Market Deals by Deal Value ($M), Brazil, 2018
- Figure 39: Medical Device Market Deals, Brazil, Top Therapy Area by Deal Value and Deal Count, 2018
- Figure 40: Ministry of Health, Structure, Brazil, 2018
- Figure 41: Departments of Ministry of Health Structure, Brazil, 2018
- Figure 42: Reimbursement Process, Brazil, 2018
- Figure 43: Roles and Responsibilities of ANS
- Figure 44: Responsibilities of CONSU
- Figure 45: OOP Expenditure (% of total expenditure on health)
- Figure 46: Annual Rate of Change (%), Consumer Price Index
- Figure 47: Categorization of Drugs, Brazil
- Figure 48: Pricing Policies, Brazil
- Figure 49: ANVISA: Organization Structure and Responsibilities
- Figure 50: ANVISA Organogram
- Figure 51: Drug Approval Process, 2016
- Figure 52: Regulatory Pathways for Dossier Registration, Brazil
- Figure 53: Biologics Approved in Brazil
- Figure 54: Regulatory Pathway for Registration of Biological Products by ANVISA
- Figure 55: Medical Device Approval Process, Brazil, 2019
- Figure 56: Medical Device Approval Timeframe and Fees, Brazil, 2019
- Figure 57: Medical Device Approval Process, Brazil, 2019
- Figure 58: Requirements of Patent Application, Brazil
- Figure 59: Details to Be Submitted for Request of Examination
- Figure 60: Trademark Requirements to Be Submitted in INPI
- Figure 61: Clinical Trial Regulation, Brazil, 2018
- Figure 62: OTC Advertising Acts Related to Prohibition, Brazil, 2018
- Figure 63: Documents to Be Submitted to ANVISA for Setting Up the Pharmacy, Brazil, 2018
- Figure 64: Circumstances Requiring Change in Pharmacy Permit, Brazil, 2018
- Figure 65: Packaging Requirements, Brazil, 2018
- Figure 66: Number of Hospitals, Brazil, 2010-2018
- Figure 67: Number of ASCs, Brazil, 2010-2018
- Figure 68: Hospital Beds (per million population), Brazil, 2010-2018
- Figure 69: Diagnostic Equipment (per million population), Brazil, 2008-2016
- Figure 70: Life Expectancy, Brazil, 2010-2016
- Figure 71: Immunization Rate (%), Brazil, 2010-2017
- Figure 72: PM2.5 (μg/m3), Brazil, 2010-2016
- Figure 73: CO2 Emissions (mt), Brazil, 2010-2016
- Figure 74: Physicians (per 1,000 population), Brazil, 2009-2018
- Figure 75: Nurses (per 1,000 population), Brazil, 2010-2018
- Figure 76: Major Causes of Mortality (number of deaths), Brazil, 2016
- Figure 77: Major Causes of Male Mortality, No. of Deaths (‘000), Brazil, 2016
- Figure 78: Major Causes of Female Mortality, No. of Deaths (‘000), Brazil, 2016
- Figure 79: Disability-Adjusted Life Years by Major Disease (‘000), Brazil, 2016
- Figure 80: Healthcare Expenditure as Percentage of GDP (%), Brazil, 2009-2017
- Figure 81: Public-Private Share (%), Brazil, 2009-2015